770-25-1-801-0016 -National CMOP NALTREXONE -(VA-25-00010070)
ID: 36C77025Q0036Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/3828dd3d822d4971a0963c69c25aafef/view
Timeline
    Description

    The Department of Veterans Affairs is seeking qualified vendors to provide Naltrexone tablets as part of a procurement initiative under solicitation number 36C77025Q0036. Vendors are required to submit their quotes by 4:00 PM CT on October 28, 2024, and must include essential documentation such as a signed SF1449 Solicitation cover page, a completed quote spreadsheet, and compliance with the Drug Supply Chain Security Act. This procurement is critical for ensuring the availability of pharmaceuticals necessary for the healthcare of veterans, reflecting the government's commitment to quality service. Interested vendors can contact Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162 for further information.

    Point(s) of Contact
    Jennifer L Knight
    (913) 684-0162
    jennifer.knight@va.gov
    Files
    Title
    Posted
    S02_Pre_SOL_36C77025Q0036_Final.pdf
    The Department of Veterans Affairs is preparing to release a presolicitation notice for the procurement of Naltrexone (EQV-Revista) 50MG tablets to be delivered to various Consolidated Mail Outpatient Pharmacies (CMOPs). The solicitation number is 36C77025Q0036, with responses due by October 28, 2024, at 4 PM Central Time. The project is categorized as full and open competition and covers pharmaceutical preparation manufacturing. The notice outlines specific details, including item numbers, quantities, and delivery requirements for multiple CMOP facilities such as Leavenworth, Chelmsford, Tucson, Lancaster, Murfreesboro, Hines, and Charleston. Vendors must submit a quotation that includes their state wholesale distributor license, ensuring compliance with the Drug Supply Chain Security Act (DSCSA). The required documentation must be emailed to the designated contract specialist, Jennifer Knight. This procurement reflects the VA's commitment to maintaining a reliable supply of critical pharmaceuticals for healthcare services to veterans, emphasizing regulatory compliance and timely delivery.
    S02_Pricing_Schedule_Q0036_final.xlsx
    The document outlines a Request for Quotation (RFQ) from the VA for the delivery of pharmaceuticals to various CMOP facilities, emphasizing the need for vendors to provide timely and compliant submissions. Specifically, vendors must deliver their quotes by 4:00 PM CT on October 28, 2024, after the solicitation posted on October 21, 2024. Required documentation includes a signed SF1449 Solicitation cover page, a completed quote spreadsheet, a valid State Wholesale Distributor License, a Trade Agreement Act Certificate, and a Sub-Contracting Plan if applicable. Vendors must specify expiration dates for all pharmaceuticals, ensuring they last at least one year from delivery. The RFQ includes detailed line item requirements for medications, particularly focusing on Naltrexone tablets across multiple CMOP facilities, with quantities specified for each location. The document serves to ensure that proposals meet defined standards and facilitate the procurement process for necessary medical supplies, demonstrating the government's commitment to maintaining healthcare service quality for veterans. Compliance with specified documentation and delivery standards is crucial for vendor selection.
    S02_RFQ_36C77025Q0036_Final.pdf
    The document outlines a Request for Proposal (RFP) by the Department of Veterans Affairs for the procurement of Naltrexone (EQV-Revita) tablets. The RFP includes details such as solicitation numbers, contact information, and proposal submission deadlines. Key requirements emphasize that all offered products must be shippable via the U.S. Postal Service, include barcoding for identification, and comply with the Drug Supply Chain Security Act. Suppliers must provide a firm commitment regarding product availability and pricing shortly before purchase orders are finalized. Additionally, compliance with specific contract clauses such as payment procedures, delivery expectations, and inspection standards is mandated. The RFP encourages participation from small businesses, particularly those eligible under various federal programs, and outlines invoice submission procedures to ensure timely processing. This procurement process reflects the government's commitment to ensure quality and accountability in acquiring pharmaceuticals for veterans while adhering to regulatory standards and promoting small business participation.
    Similar Opportunities
    6505--S0578 SEVELAMER CARBONATE 800MG TAB (VA-25-00008856)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to procure Sevelamer Carbonate 800mg tablets for delivery to multiple Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The procurement aims to ensure an adequate supply of this essential pharmaceutical, which plays a critical role in the healthcare of veterans, with a total requirement of 8,480 tablets across various locations including Leavenworth, Chelmsford, Tucson, Dallas, Murfreesboro, Great Lakes, and Charleston. Interested parties must submit their quotations by October 31, 2024, including a signed SF1449 cover page, a completed pricing schedule, a valid State Wholesale Distributor License, and a Trade Agreements Act certificate, with all submissions directed to Contract Specialist Kelley Cunningham at kelley.cunningham@va.gov.
    6505--Tadalafil Tablets (VA-24-00107372)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79724R0033 concerning the procurement of Tadalafil Tablets, intended for various federal entities, including the Department of Defense and the Bureau of Prisons. The selected contractor will be responsible for ensuring a continuous supply of Tadalafil, with a contract period of one year and four optional annual extensions, and must adhere to specific labeling and packaging requirements, including safety features for the bottles. This procurement is crucial for meeting the medication needs of veterans and other federal healthcare programs, with an estimated total annual requirement of approximately 322,854 bottles across various strengths. Interested parties should direct inquiries to Contract Specialist Billy Fong at billy.fong@va.gov, and proposals are due by November 12, 2024, following the RFP release on or about October 29, 2024.
    6505--770-25-1-801-0013 - National CMOP CHLORHEXIDINE GLUCONATE 4% TOP LIQUID (VA-24-00109489)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of CHLORHEXIDINE GLUCONATE 4% TOP LIQUID for the National CMOP facility, under solicitation number VA-24-00109489. Vendors are required to submit a signed SF1449 cover page, a completed pricing schedule, and necessary licensing documents, ensuring compliance with federal regulations, including the Buy American Act and the Drug Supply Chain Security Act. This procurement is critical for providing quality pharmaceutical supplies to veterans, emphasizing the importance of adherence to strict acceptance criteria and logistical requirements. Quotes must be submitted by October 30, 2024, at 3:00 PM Central Time, and interested parties can contact Lacie A Nowak at lacie.nowak@va.gov for further information.
    6505--Lamotrigine Immediate Release (IR) Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Lamotrigine Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care facilities, including the Department of Defense and the Bureau of Prisons. The contract will cover an unrestricted procurement for multiple strengths and packaging sizes of Lamotrigine IR Tablets, with specific requirements for labeling and packaging to ensure compliance with safety standards. This procurement is critical for maintaining the availability of essential medications for veterans and other federal beneficiaries. Interested offerors should note that the solicitation is expected to be released on or about November 7, 2024, with a closing date of November 21, 2024; inquiries can be directed to Contract Specialist Ray Roldan at raymond.roldan@va.gov or by phone at 708-786-4930.
    6505--Ketoconazole 2% Cream
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the supply of Ketoconazole 2% Cream, a pharmaceutical product essential for treating various skin conditions. Offerors are required to submit pricing for the base year and four option years, ensuring compliance with the Cost Recovery Fee of 0.5%, and must provide unique National Drug Codes (NDC) for their proposed products. This procurement aims to establish a reliable supply chain for pharmaceutical needs while adhering to federal procurement standards, emphasizing the importance of FDA cGMP compliance for manufacturers or authorized distributors. Interested parties should contact Contract Specialist Michael J Olszewski at Michael.Olszewski@va.gov for further details regarding the solicitation process.
    6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    6505--CGRP Calcitonin Gene-Related Peptides
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for a contract to supply Calcitonin gene-related peptides (CGRP) as part of its Pharmaceutical Prime Vendor (PPV) Program. The procurement aims to establish a reliable source of these pharmaceutical products, ensuring compliance with federal regulations, including the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). This initiative is crucial for maintaining consistent supply and quality control across VA medical facilities. Interested offerors must submit their proposals by October 31, 2024, at 2:30 PM CT, and can direct inquiries to Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov.
    6505--Betamethasone RFP
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the supply of Betamethasone Dipropionate Cream, a pharmaceutical product essential for the healthcare of veterans. Offerors are required to submit competitive pricing for a base year and four option years, including a mandatory 0.5% Cost Recovery Fee, while ensuring compliance with the Drug Supply Chain Security Act and Good Manufacturing Practices. This contract is vital for maintaining a consistent supply of medications through the VA and Department of Defense's Prime Vendor Programs, emphasizing the government's commitment to providing quality healthcare to service members. Interested vendors should contact Contract Specialist Amber Zavala at amber.zavala@va.gov for further details regarding the solicitation.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0046 770-25-1-801-0022 -National CMOP K0016 KETOCONAZOLE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through the National CMOP Contracting Office, is seeking to procure Ketoconazole 2% shampoo in various quantities for emergency delivery to multiple Compounding Medication Order Pharmacy (CMOP) facilities across the United States. The procurement includes specific item quantities, with a total of 27,600 units required, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and adherence to U.S. trade agreements. This acquisition is crucial for ensuring that veterans receive necessary pharmaceutical products in a timely manner. Interested vendors must submit their quotes by November 1, 2024, with an estimated award date of November 6, 2024, and should direct all inquiries and submissions to Contracting Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov.
    6505--762_Pharmaceuticals_VA CMOP Tucson_36C77025Q0045 762-25-1-040-0082 -Tucson CMOP KETOCANOZOLE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the procurement of 27,192 units of Ketoconazole 2% Shampoo, specifically packaged in 120ML bottles, to be delivered to the Tucson CMOP facility in Arizona. This presolicitation notice (Solicitation Number: 36C77025Q0045) outlines the requirement for vendors to submit a complete solicitation package, including a signed SF1449 cover page, a price schedule in Excel format, and proof of state licensure in compliance with the Drug Supply Chain Security Act (DSCSA). The procurement is crucial for ensuring the availability of essential pharmaceuticals for veteran care, with a delivery timeframe of 10 days after receipt of order (ARO) and a closing date for responses set for November 1, 2024, at 09:00 AM Central Time. Interested vendors should direct their inquiries and submissions to Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or by phone at (913) 684-0134.